Security key
76090R309
ReShape Lifesciences Inc. - Common Stock, par value $0.001 per share (RSLS)
CUSIP: 76090R309
Q1 2025 13F Holders as of 31 Mar 2025
- Type / Class
- Equity / Common Stock, par value $0.001 per share
- Shares outstanding
- 3,326,711
- Total 13F shares
- 103,713
- Share change
- +84,601
- Total reported value
- $37,359
- Price per share
- $0.36
- Number of holders
- 9
- Value change
- +$30,463
- Number of buys
- 6
- Number of sells
- 4
Report period
Q1 2025
Institutions
9
Top holders
9
RSLS full security history
Newer quarter: Q2 2025
Previous quarter: Q4 2024
Vyome Holdings, Inc SEC filings
Vyome Holdings, Inc company facts
Broader feeds
Reporting periods
Holder history for CUSIP 76090R309
Recent filing periods:
Top shareholders of RSLS - ReShape Lifesciences Inc. - Common Stock, par value $0.001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| BIGGER CAPITAL FUND L P |
13D/G
|
Bigger Michael |
9.7%
|
320,000
|
$121,600 | $0 | 18 Feb 2025 | |
| FirstFire Global Opportunities Fund LLC |
13D/G
|
— |
6.1%
|
200,000
|
$76,000 | $0 | 18 Feb 2025 | |
| Leonite Fund I, LP |
13D/G
|
— |
6.1%
|
200,000
|
$76,000 | $0 | 18 Feb 2025 | |
| Ayrton Capital LLC |
13D/G
|
— |
5.7%
|
200,000
|
$76,000 | $0 | 31 Mar 2025 | |
| CVI Investments, Inc. |
13D/G
|
— |
5.7%
|
200,000
|
$76,000 | -$54,958 | 31 Mar 2025 | |
| Dominion Capital LLC |
13D/G
|
— |
0.76%
|
25,283
|
$9,608 | -$20,149 | 18 Feb 2025 | |
| UBS Group AG |
13F
|
Company |
0.53%
|
17,665
|
$78,785 | — | 31 Dec 2024 | |
| Tower Research Capital LLC (TRC) |
13F
|
Company |
0.03%
|
847
|
$3,778 | — | 31 Dec 2024 | |
| BlackRock, Inc. |
13F
|
Company |
0.02%
|
588
|
$2,622 | — | 31 Dec 2024 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0%
|
6
|
$27 | — | 31 Dec 2024 | |
| DANSKE BANK A/S |
13F
|
Company |
0%
|
2
|
$9 | — | 31 Dec 2024 | |
| GROUP ONE TRADING LLC |
13F
|
Company |
0%
|
2
|
$9 | — | 31 Dec 2024 | |
| CIBC Private Wealth Group LLC |
13F
|
Company |
0%
|
1
|
$5 | — | 31 Dec 2024 | |
| MORGAN STANLEY |
13F
|
Company |
0%
|
1
|
$4 | — | 31 Dec 2024 | |
| OSAIC HOLDINGS, INC. |
13F
|
Company |
0%
|
1
|
$4 | — | 31 Dec 2024 | |
| SBI Securities Co., Ltd. |
13F
|
Company |
0%
|
1
|
$4 | — | 31 Dec 2024 | |
| ARMISTICE CAPITAL, LLC |
3/4/5
|
10%+ Owner |
—
class O/S missing
|
14,446,692
|
$79,167,872 | — | 28 Jun 2021 | |
| Yair Schneid |
3/4/5
|
10%+ Owner |
—
class O/S missing
|
2,461,000
|
$13,486,280 | — | 05 Jan 2024 | |
| Barton P. Bandy |
3/4/5
|
President and CEO, Director |
—
class O/S missing
|
773,098
|
$208,736 | — | 05 Aug 2022 | |
| Dan W. Gladney |
3/4/5
|
Director |
—
class O/S missing
|
283,922
|
$76,659 | — | 22 Jul 2021 | |
| Arda Minocherhomjee PhD |
3/4/5
|
Director |
—
class O/S missing
|
253,429
|
$68,426 | — | 22 Jul 2021 | |
| BLACKFORD GARY |
3/4/5
|
Director |
—
class O/S missing
|
253,429
|
$68,426 | — | 22 Jul 2021 | |
| Lori Courtney McDougal |
3/4/5
|
Director |
—
class O/S missing
|
253,429
|
$68,426 | — | 22 Jul 2021 | |
| Thomas Stankovich |
3/4/5
|
Chief Financial Officer |
—
class O/S missing
|
45,726
|
$11,890 | — | 30 Nov 2023 | |
| Cornerstone Planning Group LLC |
13F
|
Company |
—
class O/S missing
|
3
|
$13 | — | 31 Dec 2024 |
Institutional Holders of ReShape Lifesciences Inc. - Common Stock, par value $0.001 per share (RSLS) as of Q1 2025
As of 31 Mar 2025,
ReShape Lifesciences Inc. - Common Stock, par value $0.001 per share (RSLS) was held by
9 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
103,713 shares.
The largest 9 holders included
UBS Group AG, RENAISSANCE TECHNOLOGIES LLC, GEODE CAPITAL MANAGEMENT, LLC, TWO SIGMA SECURITIES, LLC, Tower Research Capital LLC (TRC), BlackRock, Inc., Federation des caisses Desjardins du Quebec, BANK OF AMERICA CORP /DE/, and GROUP ONE TRADING LLC.
This page lists
9
institutional shareholders reporting positions in this security
for the Q1 2025 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q1 2025 vs Q4 2024 Across Filers
Q4 2024 holders
9
Q1 2025 holders
9
Holder diff
0
| Investor | Q4 2024 Shares | Q1 2025 Shares | Share Diff | Share Chg % | Q4 2024 Value $ | Q1 2025 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.